{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T10:10:47Z","timestamp":1749636647226},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>This study aims to reveal the relationship between <jats:italic>AMIGO2<\/jats:italic> and proliferation, migration and tumorigenicity of bladder cancer, and explore the potential molecular mechanisms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The expression level of <jats:italic>AMIGO2<\/jats:italic> is measured by qRT-PCR and immunohistochemistry (IHC). Stable <jats:italic>AMIGO2<\/jats:italic> knockdown cell lines T24 and 5637 were established by lentivirus transfection. Cell Counting Kit (CCK-8 assay) was produced to determine cell proliferation, flow cytometry analysis was utilized to detect cell cycle, and wound healing assay was proceeded to test migration ability of bladder cancer cells. Xenograft mouse model was established for investigating the effect of <jats:italic>AMIGO2<\/jats:italic> on tumor formation in vivo. The RNA Sequencing technology was applied to explore the underlying mechanisms. The expression level of <jats:italic>PPAR-\u03b3<\/jats:italic> was measured by Western Blot.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p><jats:italic>AMIGO2<\/jats:italic> was upregulated in bladder cancer cells and tissues. Inhibited expression of <jats:italic>AMIGO2<\/jats:italic> suppresses cell proliferation and migration. Low <jats:italic>AMIGO2<\/jats:italic> expression inhibited tumorigenicity of 5637 in nude mice. According to RNA-Seq and bioinformatics analysis, 917 DEGs were identified. The DEGs were mainly enriched in cell\u2013cell adhesion, peroxisome proliferators-activated receptors (PPARs) signaling pathway and some other pathways. <jats:italic>PPAR-\u03b3<\/jats:italic> is highly expressed in bladder cancer cell lines T24 and 5637, but when <jats:italic>AMIGO2<\/jats:italic> is knocked down in T24 and 5637, the expression level of <jats:italic>PPAR-\u03b3<\/jats:italic> is also decreased, and overexpression of <jats:italic>PPAR-\u03b3<\/jats:italic> could reverse the suppression effect of cell proliferation and migration caused by the inhibition of <jats:italic>AMIGO2<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p><jats:italic>AMIGO2<\/jats:italic> is overexpressed in bladder cancer cells and tissues. Knockdown of <jats:italic>AMIGO2<\/jats:italic> suppresses bladder cancer cell proliferation and migration. These processes might be regulated by <jats:italic>PPAR-\u03b3<\/jats:italic> signaling pathway.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41065-024-00325-z","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T04:01:52Z","timestamp":1720411312000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Knockdown of AMIGO2 suppresses proliferation and migration through regulating PPAR-\u03b3 in bladder cancer"],"prefix":"10.1186","volume":"161","author":[{"given":"Dali","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaohu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqiang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,8]]},"reference":[{"issue":"3","key":"325_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"7492","key":"325_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","volume":"507","author":"Cancer Genome Atlas Research, N","year":"2014","unstructured":"Cancer Genome Atlas Research, N. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507(7492):315\u201322. https:\/\/doi.org\/10.1038\/nature12965.","journal-title":"Nature"},{"issue":"2","key":"325_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ucl.2015.02.001","volume":"42","author":"BE Boehm","year":"2015","unstructured":"Boehm BE, Svatek RS. Novel therapeutic approaches for recurrent nonmuscle invasive bladder cancer. Urol Clin North Am. 2015;42(2):159\u201368. https:\/\/doi.org\/10.1016\/j.ucl.2015.02.001.","journal-title":"Urol Clin North Am"},{"issue":"6","key":"325_CR4","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1083\/jcb.200209074","volume":"160","author":"J Kuja-Panula","year":"2003","unstructured":"Kuja-Panula J, Kiiltom\u00e4ki M, Yamashiro T, Rouhiainen A, Rauvala H. AMIGO, a transmembrane protein implicated in axon tract development, defines a novel protein family with leucine-rich repeats. J Cell Biol. 2003;160(6):963\u201373. https:\/\/doi.org\/10.1083\/jcb.200209074.","journal-title":"J Cell Biol"},{"issue":"29","key":"325_CR5","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.1038\/sj.onc.1207681","volume":"23","author":"KE Rabenau","year":"2004","unstructured":"Rabenau KE, O\u2019Toole JM, Bassi R, Kotanides H, Witte L, Ludwig DL, et al. DEGA\/AMIGO-2, a leucine-rich repeat family member, differentially expressed in human gastric adenocarcinoma: effects on ploidy, chromosomal stability, cell adhesion\/migration and tumorigenicity. Oncogene. 2004;23(29):5056\u201367. https:\/\/doi.org\/10.1038\/sj.onc.1207681.","journal-title":"Oncogene"},{"issue":"4","key":"325_CR6","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.molcel.2017.11.004","volume":"68","author":"B Fontanals-Cirera","year":"2017","unstructured":"Fontanals-Cirera B, Hasson D, Vardabasso C, Di Micco R, Agrawal P, Chowdhury A, et al. Harnessing BET inhibitor sensitivity reveals AMIGO2 as a melanoma survival gene. Mol Cell. 2017;68(4):731-744 e739. https:\/\/doi.org\/10.1016\/j.molcel.2017.11.004.","journal-title":"Mol Cell"},{"key":"325_CR7","doi-asserted-by":"publisher","first-page":"968040","DOI":"10.1155\/2012\/968040","volume":"2012","author":"S Sikka","year":"2012","unstructured":"Sikka S, Chen L, Sethi G, Kumar AP. Targeting PPARgamma signaling cascade for the prevention and treatment of prostate cancer. PPAR Res. 2012;2012:968040. https:\/\/doi.org\/10.1155\/2012\/968040.","journal-title":"PPAR Res"},{"key":"325_CR8","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1038\/onc.2011.543","volume":"31","author":"JJ Lee","year":"2012","unstructured":"Lee JJ, Drakaki A, Iliopoulos D, Iliopoulos D, Struhl K, Struhl K. MiR-27b targets PPAR\u03b3 to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells. Oncogene. 2012;31:3818\u201325. https:\/\/doi.org\/10.1038\/onc.2011.543.","journal-title":"Oncogene"},{"key":"325_CR9","doi-asserted-by":"publisher","unstructured":"Knutson SK, Chyla BJ, Amann JM, Amann JM, Bhaskara S, Bhaskara S, et al. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J . 2008;27(7):1017\u201328. https:\/\/doi.org\/10.1038\/emboj.2008.51.","DOI":"10.1038\/emboj.2008.51"},{"key":"325_CR10","doi-asserted-by":"publisher","unstructured":"Bhaskara S, Knutson SK Fau, Jiang G, Jiang G, Chandrasekharan MB, Chandrasekharan MB, et al. Hdac3 is essential for the maintenance of chromatin structure and genome stability. Cancer Cell. 2010;18(5):436\u201347. https:\/\/doi.org\/10.1016\/j.ccr.2010.10.022.","DOI":"10.1016\/j.ccr.2010.10.022"},{"issue":"13","key":"325_CR11","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.7150\/jca.42663","volume":"11","author":"T Peng","year":"2020","unstructured":"Peng T, Wang G, Cheng S, Xiong Y, Cao R, Qian K, et al. The role and function of PPARgamma in bladder cancer. J Cancer. 2020;11(13):3965\u201375. https:\/\/doi.org\/10.7150\/jca.42663.","journal-title":"J Cancer"},{"key":"325_CR12","doi-asserted-by":"publisher","first-page":"51893","DOI":"10.3791\/51893","volume":"91","author":"I Zlobec","year":"2014","unstructured":"Zlobec I, Suter G, Perren A, Lugli A. A next-generation tissue microarray (ngTMA) protocol for biomarker studies. J Vis Exp. 2014;91:51893. https:\/\/doi.org\/10.3791\/51893.","journal-title":"J Vis Exp"},{"issue":"9","key":"325_CR13","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1245\/s10434-011-1609-3","volume":"18","author":"B Wang","year":"2011","unstructured":"Wang B, Xu D, Yu X, Ding T, Rao H, Zhan Y, et al. Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection. Ann Surg Oncol. 2011;18(9):2585\u201393. https:\/\/doi.org\/10.1245\/s10434-011-1609-3.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"325_CR14","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;3(6):1101\u20138. https:\/\/doi.org\/10.1038\/nprot.2008.73.","journal-title":"Nat Protoc"},{"issue":"2","key":"325_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.canlet.2008.05.007","volume":"270","author":"A Cumashi","year":"2008","unstructured":"Cumashi A, Tinari N, Rossi C, Lattanzio R, Natoli C, Piantelli M, et al. Sunitinib malate (SU-11248) alone or in combination with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts. Cancer Lett. 2008;270(2):229\u201333. https:\/\/doi.org\/10.1016\/j.canlet.2008.05.007.","journal-title":"Cancer Lett"},{"key":"325_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13059-016-0881-8","volume":"17","author":"A Conesa","year":"2016","unstructured":"Conesa A, Madrigal P, Tarazona S, Gomez-Cabrero D, Cervera A, McPherson A, et al. A survey of best practices for RNA-seq data analysis. Genome Biol. 2016;17:13. https:\/\/doi.org\/10.1186\/s13059-016-0881-8.","journal-title":"Genome Biol"},{"issue":"3","key":"325_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"M Malumbres","year":"2009","unstructured":"Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009;9(3):153\u201366. https:\/\/doi.org\/10.1038\/nrc2602.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"325_CR18","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/j.cellsig.2008.08.011","volume":"20","author":"JC Sitko","year":"2008","unstructured":"Sitko JC, Yeh B, Kim M, Zhou H, Takaesu G, Yoshimura A, et al. SOCS3 regulates p21 expression and cell cycle arrest in response to DNA damage. Cell Signal. 2008;20(12):2221\u201330. https:\/\/doi.org\/10.1016\/j.cellsig.2008.08.011.","journal-title":"Cell Signal"},{"key":"325_CR19","doi-asserted-by":"publisher","first-page":"7475295","DOI":"10.1155\/2019\/7475295","volume":"2019","author":"MDC Lagunas-Cruz","year":"2019","unstructured":"Lagunas-Cruz MDC, Valle-Mendiola A, Trejo-Huerta J, Rocha-Zavaleta L, Mora-Garcia ML, Gutierrez-Hoya A, et al. IL-2 induces transient arrest in the G1 phase to protect cervical cancer cells from entering apoptosis. J Oncol. 2019;2019:7475295. https:\/\/doi.org\/10.1155\/2019\/7475295.","journal-title":"J Oncol"},{"issue":"10","key":"325_CR20","doi-asserted-by":"publisher","first-page":"e0163967","DOI":"10.1371\/journal.pone.0163967","volume":"11","author":"G Faura Tellez","year":"2016","unstructured":"Faura Tellez G, Willemse BW, Brouwer U, Nijboer-Brinksma S, Vandepoele K, Noordhoek JA, et al. Protocadherin-1 localization and cell-adhesion function in airway epithelial cells in asthma. PLoS One. 2016;11(10):e0163967. https:\/\/doi.org\/10.1371\/journal.pone.0163967.","journal-title":"PLoS ONE"},{"issue":"1","key":"325_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.devcel.2013.05.015","volume":"26","author":"F Tatin","year":"2013","unstructured":"Tatin F, Taddei A, Weston A, Fuchs E, Devenport D, Tissir F, et al. Planar cell polarity protein Celsr1 regulates endothelial adherens junctions and directed cell rearrangements during valve morphogenesis. Dev Cell. 2013;26(1):31\u201344. https:\/\/doi.org\/10.1016\/j.devcel.2013.05.015.","journal-title":"Dev Cell"},{"issue":"7","key":"325_CR22","doi-asserted-by":"publisher","first-page":"e0160168","DOI":"10.1371\/journal.pone.0160168","volume":"11","author":"A Ortega","year":"2016","unstructured":"Ortega A, Gil-Cayuela C, Tarazon E, Garcia-Manzanares M, Montero JA, Cinca J, et al. New Cell Adhesion Molecules in Human Ischemic Cardiomyopathy. PCDHGA3 Implications in decreased stroke volume and ventricular dysfunction. PLoS One. 2016;11(7):e0160168. https:\/\/doi.org\/10.1371\/journal.pone.0160168.","journal-title":"PLoS ONE"},{"issue":"5","key":"325_CR23","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1038\/13043","volume":"1","author":"S Huang","year":"1999","unstructured":"Huang S, Ingber DE. The structural and mechanical complexity of cell-growth control. Nat Cell Biol. 1999;1(5):E131\u20138. https:\/\/doi.org\/10.1038\/13043.","journal-title":"Nat Cell Biol"},{"key":"325_CR24","doi-asserted-by":"publisher","first-page":"43567","DOI":"10.1038\/srep43567","volume":"7","author":"Y Kanda","year":"2017","unstructured":"Kanda Y, Osaki M, Onuma K, Sonoda A, Kobayashi M, Hamada J, et al. Amigo2-upregulation in tumour cells facilitates their attachment to liver endothelial cells resulting in liver metastases. Sci Rep. 2017;7:43567. https:\/\/doi.org\/10.1038\/srep43567.","journal-title":"Sci Rep"},{"key":"325_CR25","doi-asserted-by":"publisher","first-page":"340218","DOI":"10.1155\/2015\/340218","volume":"2015","author":"J Chen","year":"2015","unstructured":"Chen J, Gu L, Ni J, Hu P, Hu K, Shi YL. MiR-183 regulates ITGB1P expression and promotes invasion of endometrial stromal cells. Biomed Res Int. 2015;2015:340218. https:\/\/doi.org\/10.1155\/2015\/340218.","journal-title":"Biomed Res Int"},{"issue":"1","key":"325_CR26","doi-asserted-by":"publisher","first-page":"12262","DOI":"10.1038\/s41598-017-12135-7","volume":"7","author":"J Carabia","year":"2017","unstructured":"Carabia J, Carpio C, Abrisqueta P, Jimenez I, Purroy N, Calpe E, et al. Microenvironment regulates the expression of miR-21 and tumor suppressor genes PTEN, PIAS3 and PDCD4 through ZAP-70 in chronic lymphocytic leukemia. Sci Rep. 2017;7(1):12262. https:\/\/doi.org\/10.1038\/s41598-017-12135-7.","journal-title":"Sci Rep"},{"issue":"11","key":"325_CR27","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41419-019-2082-3","volume":"10","author":"HE Zhu","year":"2019","unstructured":"Zhu HE, Yin JY, Chen DX, He S, Chen H. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K\/Akt pathway. Cell Death Dis. 2019;10(11):854. https:\/\/doi.org\/10.1038\/s41419-019-2082-3.","journal-title":"Cell Death Dis"},{"key":"325_CR28","doi-asserted-by":"publisher","first-page":"34625","DOI":"10.1038\/srep34625","volume":"6","author":"R Matsumoto","year":"2016","unstructured":"Matsumoto R, Tsuda M, Yoshida K, Tanino M, Kimura T, Nishihara H, et al. Aldo-keto reductase 1C1 induced by interleukin-1beta mediates the invasive potential and drug resistance of metastatic bladder cancer cells. Sci Rep. 2016;6:34625. https:\/\/doi.org\/10.1038\/srep34625.","journal-title":"Sci Rep"},{"issue":"Pt A","key":"325_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jsbmb.2015.09.037","volume":"155","author":"CL Doig","year":"2016","unstructured":"Doig CL, Battaglia S, Khanim FL, Bunce CM, Campbell MJ. Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cells. J Steroid Biochem Mol Biol. 2016;155(Pt A):47\u201355. https:\/\/doi.org\/10.1016\/j.jsbmb.2015.09.037.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"325_CR30","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1158\/1535-7163.MCT-18-1322","volume":"18","author":"C Liu","year":"2019","unstructured":"Liu C, Yang JC, Armstrong CM, Lou W, Liu L, Qiu X, et al. AKR1C3 promotes AR-V7 protein stabilization and confers resistance to AR-targeted therapies in advanced prostate cancer. Mol Cancer Ther. 2019;18(10):1875\u201386. https:\/\/doi.org\/10.1158\/1535-7163.MCT-18-1322.","journal-title":"Mol Cancer Ther"},{"key":"325_CR31","first-page":"505","volume":"63","author":"CD Julian","year":"2003","unstructured":"Julian CD, et al. The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. Cancer Res. 2003;63:505\u201312.","journal-title":"Cancer Res"},{"issue":"33","key":"325_CR32","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1038\/onc.2011.543","volume":"31","author":"JJ Lee","year":"2012","unstructured":"Lee JJ, Drakaki A, Iliopoulos D, Struhl K. MiR-27b targets PPARgamma to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells. Oncogene. 2012;31(33):3818\u201325. https:\/\/doi.org\/10.1038\/onc.2011.543.","journal-title":"Oncogene"},{"issue":"8","key":"325_CR33","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/ijms17081226","volume":"17","author":"HT Hsu","year":"2016","unstructured":"Hsu HT, Sung MT, Lee CC, Kuo YJ, Chi CW, Lee HC, et al. Peroxisome proliferator-activated receptor gamma expression is inversely associated with macroscopic vascular invasion in human hepatocellular carcinoma. Int J Mol Sci. 2016;17(8):1226. https:\/\/doi.org\/10.3390\/ijms17081226.","journal-title":"Int J Mol Sci"},{"key":"325_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1476-4598-7-90","volume":"7","author":"YY Zaytseva","year":"2008","unstructured":"Zaytseva YY, Wang X, Southard RC, Wallis NK, Kilgore MW. Down-regulation of PPARgamma1 suppresses cell growth and induces apoptosis in MCF-7 breast cancer cells. Mol Cancer. 2008;7:90. https:\/\/doi.org\/10.1186\/1476-4598-7-90.","journal-title":"Mol Cancer"},{"issue":"14 Pt 1","key":"325_CR35","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1158\/1078-0432.CCR-05-1833","volume":"12","author":"K Ota","year":"2006","unstructured":"Ota K, Ito K, Suzuki T, Saito S, Tamura M, Hayashi S, et al. Peroxisome proliferator-activated receptor gamma and growth inhibition by its ligands in uterine endometrial carcinoma. Clin Cancer Res. 2006;12(14 Pt 1):4200\u20138. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-1833.","journal-title":"Clin Cancer Res"},{"key":"325_CR36","doi-asserted-by":"publisher","unstructured":"Han D, Xiong B, Zhang X, Chen C, Yao Z, Wu H, et al. Effects and mechanisms of AMIGO2 in proliferation migration and drug resistance of bladder cancer. 2020. https:\/\/doi.org\/10.21203\/rs.3.rs-34249\/v1.","DOI":"10.21203\/rs.3.rs-34249\/v1"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-024-00325-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-024-00325-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-024-00325-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T04:04:06Z","timestamp":1720411446000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-024-00325-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,8]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1186\/s41065-024-00325-z","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,8]]},"assertion":[{"value":"15 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project was approved by the Institutional Research Ethics Committee of the Second Hospital of Lanzhou University (No. 2019A-119 and No. D2019-171). The ethical approval and the informed consent were supplied in attachment files.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Included.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}